过敏性鼻炎中的免疫调节:Th2细胞和NLRP3/IL-18通路的洞察
Xiaoyan Hu1,2, Shuang Liu3, Zhang Jing3
1Department of Pathogen Biology, School of Basic Medicine Southwest Medical University, Luzhou, China.
Cell biochemistry and function
|March 31, 2024
概括
这项研究揭示了NLRP3炎症酶激活和巨细胞灭通过促进Th2细胞分化来驱动过敏性鼻炎 (AR). 使用MCC950抑制NLRP3有效降低AR症状和炎症.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏研究 研究过敏
- 细胞生物学 细胞生物学
背景情况:
- 过敏性鼻炎 (AR) 涉及由过敏原引发的鼻腔症状.
- 炎细胞和巨细胞在AR病原发生中的作用尚未完全理解.
- 在过敏免疫反应中,T细胞分化至关重要.
研究的目的:
- 为了研究NLRP3炎酶酶介导免疫调节和巨细胞灭在T细胞分化中的参与,在卵蛋白 (OVA) 诱导的AR的小鼠模型中.
- 探索在AR中准NLRP3途径的治疗潜力.
主要方法:
- 在小鼠中确定OVA诱导的AR.
- 使用了NLRP3-/-和ASC-/-淘汰赛小鼠.
- 用于对巨细胞枯竭的克洛德罗纳酸脂质体和MCC950作为NLRP3抑制剂.
- 评估了鼻腔症状,巨细胞透,细胞因子水平 (IL-4,IL-1b,IL-18),IgE水平和T细胞分化 (GATA3,CD3+T细胞).
主要成果:
- 由OVA诱导的AR小鼠表现出鼻腔症状增加,Th2极化 (GATA3,IL-4升高) 和热的标志物 (IL-1b).
- 在AR中,NLRP3和ASC缺乏减少了T细胞透.
- 巨细胞枯竭降低了IgE水平,而增强的巨细胞灭会影响Th1/Th2平衡.
- 来自热的IL-18促进了Th2分化,而MCC950治疗通过调节Th2反应和减少巨细胞透来缓解AR症状.
结论:
- 通过NLRP3介导的免疫调节和巨细胞灭在调节OVA诱导的AR中的Th1/Th2平衡方面发挥着重要作用.
- 用MCC950准NLRP3通路是一种有前途的治疗策略,用于管理AR症状.
- 这项研究为AR背后的机制和潜在的治疗途径提供了新的见解.
更多相关视频
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
7.7K
07:46Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation
Published on: October 25, 2024
3.0K
相关概念视频
01:24T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
02:06Allergic Reactions
27.3K
Overview
27.3K
01:17Drugs Used in Lower Respiratory Disorders: Overview
437
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
437
01:28Inflammatory Response
2.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.0K